Company

Medite Cancer Diagnostics, Inc. (0000075439)

Standardized SEC financial data for Medite Cancer Diagnostics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000075439 · Surgical & Medical Instruments & Apparatus.

Gross margin

2.4%

Operating margin

-95.1%

Net margin

-100.0%

Revenue growth (YoY)

-26.3%

Return on equity

-117.9%

ROIC

-48.7%

Free cash flow

-$3.6M

Debt / equity

0.83×

Ratios for fiscal year 2017, standardized from SEC filings.

Income statement

USD	FY2016	FY2017
Revenue	$9.2M	$6.8M
Cost of revenue	$5.6M	$6.7M
Gross profit	$3.6M	$162K
R&D expense	$1.5M	$1.2M
Operating income	-$1.7M	-$6.5M
EBITDA	-$1.4M	-$6.2M
Interest expense

Balance sheet

USD	FY2016	FY2017
Cash & equivalents	$108K	$73K
Inventory	$3.8M	$2.4M
Total current assets	$5.3M	$3.5M
Property, plant & equipment	$1.6M	$1.8M
Goodwill	$4.7M	$4.7M
Total assets	$17.6M	$16.0M
Total current liabilities

Cash flow

USD	FY2016	FY2017
Operating cash flow	-$1.1M	-$3.6M
Capital expenditures	$0	—
Free cash flow	-$1.1M	—
Investing cash flow	-$115K	-$134K
Financing cash flow	$700K	$3.5M

Get 0000075439 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0000075439/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0000075439/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0000075439 filings on SEC EDGAR →